3D Bioprinting Market by Application, Solution, and Geography - Forecast and Analysis 2023-2027

Published: Oct 2023 Pages: 170 SKU: IRTNTR45869

3D Bioprinting Market Size 2023-2027

The Global 3D Bioprinting Market size is estimated to grow by USD 2.02 billion, at a CAGR of 19.94% between 2022 and 2027. The growth of the market depends on several factors, including the rising cost efficiency and enhanced productivity, the advancements in technology, and the increased demand for personalized or customized orthopaedic devices. Challenges such as high initial costs to set up a 3D printing facility, the inability of researchers to combine vascular supply in printed tissues and organs, and the limited availability of suitable biomaterials might hamper the growth of the market. Nevertheless, trends such as developments in scaffold-free bioprinting, bio-fabrication of complex tissues, and the rising focus on R&D of 3D bioprinting will boost the growth of the market.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation

This market research and growth report extensively covers market segmentation by application (human tissue and organ generation, medical testing, dental, prosthetics, and others), solution (3d bioprinters, bioprinting materials, and services and ancillary equipment), and geography (North America, Europe, Asia, and Rest of World (ROW)).

Market Dynamics and Customer Landscape

The market is driven by the aging population's increasing demand for advanced medical treatments. Innovations like biotherapeutics and artificial organs propel market growth. Companies like Viscient Biosciences and Stratasys pioneer inkjet-based and laser-assisted bioprinting technologies, enabling precise drug delivery and organ fabrication. However, challenges like ensuring proper respiratory epithelium integration and preventing potential damage during the printing process persist. Despite these hurdles, 3D bioprinting holds immense promise in revolutionizing healthcare by offering personalized medical solutions and addressing critical organ shortages. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

Market expansion is notably fueled by advancements in 3D bioprinting technology, characterized by ongoing improvements in bio-ink formulations, printing methods, and tissue engineering strategies. These enhancements facilitate the creation of intricate tissue structures, revolutionizing regenerative medicine. Novel bio-ink formulations enhance cell survival and tissue fusion, enabling personalized structures for patients. Enhanced printing methods, utilizing multiple printheads, enable precise deposition of various cell types and materials, yielding intricate tissue constructs.

Further, innovative tissue engineering methods, such as bioprinting on pre-pasteurized substrates, offer promising options for robust tissue fabrication. Consequently, 3D bioprint technology fosters market growth, pushing boundaries in regenerative medicine and personalized healthcare. Expectations for substantial market expansion remain high, driven by these transformative advancements.

Significant Market Trends

The fabrication of complex tissues is a primary trend in the market share. The focus on fabricating complex tissues and multi-organ complexes is a prominent trend in the market. To create functioning tissues with complex structures, researchers are investigating the simultaneous printing of several cell types, extracellular matrix, and growth hormones. 

Moreover, the development of multi-organ complexes and complex tissues that can be printed holds great promise for the future of personalized healthcare and regenerative medicine. In view of that fact, this trend is anticipated to have a strong impact on the market growth and trends over the forecast period and will be instrumental in its growth.

Major Market Challenge

The inability of researchers to combine vascular supply in printed tissues and organs is a major challenge in the market. Although the market has witnessed breakthroughs over the years, it is far from bioprinting a fully functional organ or tissue for transplant. The researchers are successful in bioprinting parts of an organ or tissue that has cells fully capable of performing their dedicated functions. However, they have not been able to combine vascular veins in the printed organs, though they can be printed separately. The bioprinted product needs the vascular vein network and the necessary blood flow in it to work.

However, without the vascular system, the thickness of the tissue is limited.  Growth in the focus market would be limited until an intact organ has been developed and readiness for transplantation is achieved. It does not envisage that this technology will be commercially available to end users in the future. Consequently, it is expected that a challenge to the growth of the market in focus over the forecast period will be researchers' failure to combine blood vessel supply for printing tissues and organs.

Key Customer Landscape

The market trends and analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Market Segmentation By Application

The market is driven by the ageing population's increasing demand for advanced medical treatments. Innovations like biotherapeutics and artificial organs propel market growth. Companies like Viscient Biosciences and Stratasys pioneer inkjet-based and laser-assisted bioprinting technologies, enabling precise drug delivery and organ fabrication. However, challenges like ensuring proper respiratory epithelium integration and preventing potential damage during the printing process persist. Despite these hurdles, 3D bioprinting holds immense promise in revolutionizing healthcare by offering personalized medical solutions and addressing critical organ shortages.

The market share growth by the human tissue and organ generation segment will be significant during the forecast period. Human tissue and organ generation can reduce the waiting period for patients who need organ donors. The other benefit of using 3D-bioprinted organs is that the chances of the patient's body rejecting the implant are reduced to a bare minimum. Organ implants from donors are often rejected by the patient's body leading to complications post-implantation.

Get a glance at the market contribution of various segments View the PDF Sample

This human tissue and organ generation shows a gradual increase in the market share of USD 221.27 million in 2017 and continue to grow by 2021. Although the technology for printing organs is still in the developmental stage, laboratories, and research organizations have successfully developed a human kidney. However, bio-printed organs were not ready for human trials till 2017. The demand for 3D bioprinting in the Human tissue and organ generation application is expected to increase and hence drive the growth of the market in focus during the forecast period.

Key Regions

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 31% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America accounted for the largest revenue share of the global market in 2022. The US and Canada are the significant revenue contributors to the market in focus in North America. The growth of the market in focus in the region can be attributed to improved healthcare infrastructure, high adoption of 3D bioprinting technologies in healthcare facilities, and the presence of established companies. 

Who are the Major Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

3D Bioprinting Solutions - The company offers 3D bioprinting such as Fabion 2 and Viscoll.

The market growth and forecasting report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • Advanced Solutions Inc.
  • Aspect Biosystems Ltd.
  • BICO Group AB
  • CollPlant Biotechnologies Ltd.
  • Cyfuse Biomedical K.K.
  • Desktop Metal Inc.
  • Foldink
  • GE Healthcare Technologies Inc.
  • Hangzhou Jienuofei Biotechnology Co. Ltd.
  • Inventia Life Science Pty Ltd.
  • Organovo Holdings Inc.
  • Pandorum Technologies Pvt. Ltd.
  • Poietis
  • Precise Bio Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2023 to 2027, as well as historical data from 2017 to 2021 for the following segments

  • Application Outlook 
    • Human tissue and organ generation
    • Medical testing
    • Dental
    • Prosthetics
    • Others
  • Solution Outlook 
    • 3D bioprinters
    • Bioprinting materials
    • Services and ancillary equipment
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Rest of the world

Market Analyst Overview

The market is at the forefront of medical innovation, addressing critical healthcare needs driven by the aging population. With advancements in technology and skilled professionals, 3D bioprinting enables the creation of intricate structures like respirators, ventilators, and biotherapeutic implants. This transformative technology facilitates the precise printing of artificial skin, hair follicles, and even organ transplants from donor organs or natural tissues, reducing the reliance on immunosuppressants. Through processes like magnetic levitation and extrusion-based printing, bioprinters fabricate living tissues with high cell viability, crucial for applications such as toxicity screening and vascular muscle printing. Moreover, 3D bioprinting plays a pivotal role in drug development and toxicity screening, offering insights through patent analysis and bioassays. As the market evolves, the integration of metals and plastics expands the possibilities for 3D-printed skin and bone grafts, driving advancements towards a future of personalized medicine and regenerative therapies.

Further, the market thrives on technological advancements, offering groundbreaking solutions in bioengineering and human cell regeneration. From intricate nasopharyngeal swab to precision BioAssay, 3D printers revolutionize medical diagnostics and drug development. This innovative approach extends to manufacturing medical pills tailored to individual needs, shaping buying behaviour in the healthcare sector. With meticulous process control, bioprinters ensure the viability of living cells and the precise deposition of drug molecules, propelling research in personalized medicine. Utilizing extrusion-based techniques, bioprinting paves the way for unparalleled advancements in tissue engineering and regenerative therapies. As the market evolves, the integration of 3D bioprinting continues to redefine healthcare, offering hope for improved patient outcomes and transformative medical treatments.

Market Scope

Market Report Coverage

Details

Page number

170

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 19.94%

Market growth 2023-2027

USD 2.02 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

19.82

Regional analysis

North America, Europe, Asia, and Rest of the World (ROW)

Performing market contribution

North America at 31%

Key countries

US, Canada, Germany, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

3D Bioprinting Solutions, 3D Systems Corp., Advanced Solutions Inc., Aspect Biosystems Ltd., BICO Group AB, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal Inc., Foldink, GE Healthcare Technologies Inc., Hangzhou Jienuofei Biotechnology Co. Ltd., Inventia Life Science Pty Ltd., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Poietis, Precise Bio Inc., regenHU Ltd., and ROKIT Healthcare Inc.

Market dynamics

Parent market growth analysis, Market Forecasting,  Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the market forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of the World (ROW)
  • Through analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Solution
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global 3D bioprinting market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global 3d bioprinting market 2017 - 2021 ($ million)
    • 4.2 Application Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.3 Solution Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Solution Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Human tissue and organ generation - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Human tissue and organ generation - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Human tissue and organ generation - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Human tissue and organ generation - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Human tissue and organ generation - Year-over-year growth 2022-2027 (%)
    • 6.4 Medical testing - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Medical testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Medical testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Medical testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Medical testing - Year-over-year growth 2022-2027 (%)
    • 6.5 Dental - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Dental - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Dental - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Dental - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Dental - Year-over-year growth 2022-2027 (%)
    • 6.6 Prosthetics - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Prosthetics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Prosthetics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Prosthetics - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Prosthetics - Year-over-year growth 2022-2027 (%)
    • 6.7 Others - Market size and forecast 2022-2027
      • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.8 Market opportunity by Application
      • Exhibit 54: Market opportunity by Application ($ million)
      • Exhibit 55: Data Table on Market opportunity by Application ($ million)

    7 Market Segmentation by Solution

    • 7.1 Market segments
      • Exhibit 56: Chart on Solution - Market share 2022-2027 (%)
      • Exhibit 57: Data Table on Solution - Market share 2022-2027 (%)
    • 7.2 Comparison by Solution
      • Exhibit 58: Chart on Comparison by Solution
      • Exhibit 59: Data Table on Comparison by Solution
    • 7.3 3D bioprinters - Market size and forecast 2022-2027
      • Exhibit 60: Chart on 3D bioprinters - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on 3D bioprinters - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on 3D bioprinters - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on 3D bioprinters - Year-over-year growth 2022-2027 (%)
    • 7.4 Bioprinting materials - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Bioprinting materials - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Bioprinting materials - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Bioprinting materials - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Bioprinting materials - Year-over-year growth 2022-2027 (%)
    • 7.5 Services and ancillary equipment - Market size and forecast 2022-2027
      • Exhibit 68: Chart on Services and ancillary equipment - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Data Table on Services and ancillary equipment - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Chart on Services and ancillary equipment - Year-over-year growth 2022-2027 (%)
      • Exhibit 71: Data Table on Services and ancillary equipment - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Solution
      • Exhibit 72: Market opportunity by Solution ($ million)
      • Exhibit 73: Data Table on Market opportunity by Solution ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 76: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 111: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 112: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 113: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ million)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 3D Bioprinting Solutions
              • Exhibit 123: 3D Bioprinting Solutions - Overview
              • Exhibit 124: 3D Bioprinting Solutions - Product / Service
              • Exhibit 125: 3D Bioprinting Solutions - Key offerings
            • 12.4 3D Systems Corp.
              • Exhibit 126: 3D Systems Corp. - Overview
              • Exhibit 127: 3D Systems Corp. - Business segments
              • Exhibit 128: 3D Systems Corp. - Key news
              • Exhibit 129: 3D Systems Corp. - Key offerings
              • Exhibit 130: 3D Systems Corp. - Segment focus
            • 12.5 Advanced Solutions Inc.
              • Exhibit 131: Advanced Solutions Inc. - Overview
              • Exhibit 132: Advanced Solutions Inc. - Product / Service
              • Exhibit 133: Advanced Solutions Inc. - Key offerings
            • 12.6 Aspect Biosystems Ltd.
              • Exhibit 134: Aspect Biosystems Ltd. - Overview
              • Exhibit 135: Aspect Biosystems Ltd. - Product / Service
              • Exhibit 136: Aspect Biosystems Ltd. - Key offerings
            • 12.7 BICO Group AB
              • Exhibit 137: BICO Group AB - Overview
              • Exhibit 138: BICO Group AB - Business segments
              • Exhibit 139: BICO Group AB - Key offerings
              • Exhibit 140: BICO Group AB - Segment focus
            • 12.8 CollPlant Biotechnologies Ltd.
              • Exhibit 141: CollPlant Biotechnologies Ltd. - Overview
              • Exhibit 142: CollPlant Biotechnologies Ltd. - Product / Service
              • Exhibit 143: CollPlant Biotechnologies Ltd. - Key offerings
            • 12.9 Cyfuse Biomedical K.K.
              • Exhibit 144: Cyfuse Biomedical K.K. - Overview
              • Exhibit 145: Cyfuse Biomedical K.K. - Product / Service
              • Exhibit 146: Cyfuse Biomedical K.K. - Key offerings
            • 12.10 Desktop Metal Inc.
              • Exhibit 147: Desktop Metal Inc. - Overview
              • Exhibit 148: Desktop Metal Inc. - Business segments
              • Exhibit 149: Desktop Metal Inc. - Key news
              • Exhibit 150: Desktop Metal Inc. - Key offerings
              • Exhibit 151: Desktop Metal Inc. - Segment focus
            • 12.11 GE Healthcare Technologies Inc.
              • Exhibit 152: GE Healthcare Technologies Inc. - Overview
              • Exhibit 153: GE Healthcare Technologies Inc. - Business segments
              • Exhibit 154: GE Healthcare Technologies Inc. - Key offerings
              • Exhibit 155: GE Healthcare Technologies Inc. - Segment focus
            • 12.12 Hangzhou Jienuofei Biotechnology Co. Ltd.
              • Exhibit 156: Hangzhou Jienuofei Biotechnology Co. Ltd. - Overview
              • Exhibit 157: Hangzhou Jienuofei Biotechnology Co. Ltd. - Product / Service
              • Exhibit 158: Hangzhou Jienuofei Biotechnology Co. Ltd. - Key offerings
            • 12.13 Inventia Life Science Pty Ltd.
              • Exhibit 159: Inventia Life Science Pty Ltd. - Overview
              • Exhibit 160: Inventia Life Science Pty Ltd. - Product / Service
              • Exhibit 161: Inventia Life Science Pty Ltd. - Key offerings
            • 12.14 Organovo Holdings Inc.
              • Exhibit 162: Organovo Holdings Inc. - Overview
              • Exhibit 163: Organovo Holdings Inc. - Business segments
              • Exhibit 164: Organovo Holdings Inc. - Key offerings
              • Exhibit 165: Organovo Holdings Inc. - Segment focus
            • 12.15 Poietis
              • Exhibit 166: Poietis - Overview
              • Exhibit 167: Poietis - Product / Service
              • Exhibit 168: Poietis - Key offerings
            • 12.16 regenHU Ltd.
              • Exhibit 169: regenHU Ltd. - Overview
              • Exhibit 170: regenHU Ltd. - Product / Service
              • Exhibit 171: regenHU Ltd. - Key offerings
            • 12.17 ROKIT Healthcare Inc.
              • Exhibit 172: ROKIT Healthcare Inc. - Overview
              • Exhibit 173: ROKIT Healthcare Inc. - Product / Service
              • Exhibit 174: ROKIT Healthcare Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 175: Inclusions checklist
                • Exhibit 176: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 177: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 178: Research methodology
                • Exhibit 179: Validation techniques employed for market sizing
                • Exhibit 180: Information sources
              • 13.5 List of abbreviations
                • Exhibit 181: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              3d bioprinting market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis